The opportunity is not a final award announcement. DOE will make future competitive awards to qualifying for-profit small businesses that meet Small Business Administration eligibility rules. Prior DOE SBIR/STTR Phase I, Phase II and Follow-on Phase II recipients are expected to receive direct outreach with application requirements and timelines.

DOE also announced a separate FY26 Phase I opportunity tied to its Genesis Mission on the same date. That Phase I release is distinct from the approximately $147 million FY25 Phase II opportunity covered here.

What Phase II funding supports

SBIR and STTR are competitive, nondilutive programs, meaning the federal funding does not require a company to give up ownership in exchange for the award. DOE describes the general pathway as Phase I feasibility work, Phase II development and prototyping, and Phase III or other follow-on opportunities aimed at commercialization.

Phase II is therefore intended for technologies that have already completed earlier feasibility work. It can help a company improve a prototype, address technical risks and prepare for later commercial development. It is not the same as a commercial contract, a guarantee of market adoption or proof that a product will reach customers.

STTR projects involve a small business working with a research institution. DOE also identifies universities, national laboratories, federally funded research and development centers, manufacturing firms and engineering partners as possible sources of expertise or facilities, depending on the stage of development.

DOE has moved the programs under one office

The funding round follows an April 28, 2026 overhaul in which DOE consolidated SBIR and STTR management under its Office of Technology Commercialization. DOE said the change is intended to improve efficiency, strengthen commercialization pathways, streamline the applicant experience and deepen engagement between small businesses and the department’s national laboratories.

The department’s stated goal is to help narrow the gap between federally supported research and technologies that can attract customers, investment or follow-on support. That is an intended policy outcome, not evidence that the newly opened funding round will produce particular jobs, products or market share.

Independent context comes from Federal News Network, which reported in July on parallel National Science Foundation efforts to help move promising research toward commercial use. The broader federal push reflects concern about the so-called “valley of death” between laboratory results and private-sector investment.

Security reviews are part of the application process

Applicants will face more than a technical-merit review. DOE says security risk is reviewed separately, and Phase II applicants must submit a cybersecurity self-assessment. The department says the detailed requirements for that assessment will be included in the applicable Phase II funding announcement.

DOE’s due-diligence process addresses foreign affiliations, foreign ownership and financial relationships, technology licensing agreements, joint ventures and business relationships involving entities or individuals in countries of concern. It also examines connections to specified sanctions and restricted-party lists.

The 2026 law expanded the categories agencies must consider, including certain affiliations involving covered individuals, owners or key personnel; investment relationships; licensing or joint ventures; and business relationships with entities or individuals in a foreign country of concern. DOE says it may decline to fund applications presenting unacceptably high foreign risk.

That does not mean every foreign connection automatically disqualifies an applicant. The department describes the process as a risk review separate from technical scoring. Small businesses are encouraged to vet employees, investors and partners and to strengthen protections for intellectual property and research information.

Congress extended SBIR and STTR through 2031

Congress enacted the Small Business Innovation and Economic Security Act on April 13, 2026, as Public Law 119-83. The law reauthorized SBIR and STTR through September 30, 2031, and added national-security, accountability and innovation reforms.

The practical effect is that commercialization planning and compliance preparation now sit closer together. Companies and research partners should be prepared to document ownership, affiliations, licensing arrangements, key personnel relationships and cybersecurity practices before applying.

What applicants should do next

DOE says applicants must complete three registrations before submitting an application: registration in the System for Award Management, the SBA Company Registry and the DOE SBIR/STTR Application Hub. DOE warns that SAM registration can take up to eight weeks, so businesses should not wait until the application deadline to begin.

Applicants should also monitor DOE’s formal instructions for topic-specific requirements, deadlines, registration rules and the details of the cybersecurity self-assessment. The next concrete measure of the program’s impact will be the awards DOE ultimately makes and the technologies that recipients can move from development into later commercial opportunities.

Sources

• DOE SBIR/STTR program page
• Small Business Innovation and Economic Security Act, Public Law 119-83
• Federal News Network: The federal government is going beyond funding research

DOE also announced a fiscal year 2026 Genesis Mission Phase I opportunity that is expected to produce about 40 awards. The first topics include biotechnology, quantum systems, predictable-functionality materials and artificial-intelligence-driven autonomous laboratories.

The development is a change in access to potential federal funding, not a final award decision. The approved materials do not identify awardees, and the approximately $147 million figure should not be treated as money guaranteed to every applicant.

What DOE announced

The approximately $147 million applies to the FY2025 Phase II SBIR/STTR opportunities. Phase II follows the programs’ initial research stage and is intended to support continued technology development. The funding opportunities are available nationwide to eligible U.S. for-profit small businesses and technology-transfer applicants.

The separate Genesis Mission opportunity is a FY2026 Phase I program. DOE anticipates about 40 awards under that opportunity, although the announcement does not mean that those awards have already been selected.

The initial Genesis topics cover several parts of the research-to-market pipeline. Biotechnology, quantum systems and advanced materials can involve long development cycles, while autonomous laboratories use artificial intelligence to support laboratory research and experimentation. The packet identifies the targeted areas but does not provide individual award amounts or say how many awards will be made in each topic.

A reorganization of the programs

The funding opportunities are being introduced as DOE changes how its small-business innovation and commercialization programs are managed. On April 28, 2026, the department documented an overhaul that consolidated SBIR and STTR management under its Office of Technology Commercialization.

SBIR and STTR use a phased structure. Companies and other eligible applicants can move from Phase I to Phase II and potentially to Phase III commercialization. In practical terms, the structure is intended to provide a path from early research to further development and, eventually, commercial activity.

That pathway matters for small businesses developing technologies that may require additional research, testing and engineering before they can become products or services. Federal support can help applicants pursue that work without making the announcement a promise of commercial success or a replacement for private investment.

The covered technology areas also extend beyond one narrow startup sector. The approved materials identify relevance to advanced manufacturing, biotechnology, quantum technology, semiconductors and energy-related innovation. The immediate effect is to create or publicize opportunities for eligible applicants; the materials do not establish that the reorganization has already increased commercialization results.

What happens next

DOE said a broader Phase I opportunity is expected later in fall 2026. Its final scope and award count had not been posted in the approved materials. That means potential applicants have a future opportunity to watch for, but the packet does not provide a specific application deadline for that broader round.

Congress also extended the SBIR and STTR programs through fiscal year 2031 in the Small Business Innovation and Economic Security Act of 2026. The extension gives the programs a longer statutory horizon while DOE changes their administrative structure and adds the Genesis Mission opportunity.

For applicants, the immediate developments are the July 22 opening of the FY2025 Phase II opportunities and the publication of the initial FY2026 Genesis Mission Phase I opportunity. The next major scheduled step identified by DOE is the broader Phase I opportunity expected in fall 2026.

The approved materials do not include final selections, individual award amounts or evidence that the new structure has produced better commercialization outcomes. Those details will be necessary to assess how the funding changes affect the companies and technologies that eventually receive support.

The opportunities, announced July 22, 2026, are part of DOE’s Small Business Innovation Research and Small Business Technology Transfer programs, commonly known as SBIR and STTR. The funding is designated for Phase II work, which supports companies continuing development after earlier research activity.

What the funding is intended to do

DOE says the Phase II opportunities are designed to advance technologies toward commercialization. That places the funding at a transition point between research and the practical work required to develop an innovation for potential market deployment.

For eligible small businesses, the opportunity is significant because the support is described as non-dilutive. The program is also competitive, meaning companies must compete for the available federal funding rather than receiving it automatically upon eligibility.

The announcement does not identify a particular startup as a recipient. It describes an opportunity open to eligible American small businesses nationwide, not a completed distribution of awards to named companies.

DOE’s announcement also does not specify the eventual number of awards or the maximum amount available for an individual award. Those details matter to companies assessing whether the opportunity can support a full development phase or only part of a project.

Part of a broader commercialization effort

The Phase II opportunity fits within a broader DOE approach to moving technologies from research into use. The department’s Technology Commercialization Fund materials describe commercialization programs that combine federal support with private or public cost sharing to help technologies reach market readiness.

That broader context does not establish that every SBIR or STTR Phase II award will use the same cost-sharing structure. It does show how DOE frames commercialization: as a process that requires more than an initial research result and may involve additional support as a technology advances toward the market.

For small technology companies, the practical question is whether a project that has completed earlier research can now secure enough support to continue development. Phase II funding is aimed at that next stage, while remaining focused on technologies that DOE says have commercial potential.

What happens next

The July 22 opening date marks the start of the funding opportunity, not the announcement of final awards. The supplied DOE materials do not state an application deadline, an award schedule or the number of companies that will ultimately receive support.

Applicants and other observers will therefore need to consult the program’s official opportunity details for the requirements and timing that govern submissions. Until DOE publishes or identifies those details, the confirmed information is the total amount made available, the Phase II designation, the competitive and non-dilutive structure, and the program’s commercialization goal.

The opportunity gives small businesses developing new technologies a federal route to continue work beyond earlier research. Its broader significance will depend on which companies are selected, how much each receives and whether the supported technologies progress toward market deployment.

The openings create federal funding paths for companies working on technologies with commercial potential, including biotechnology, quantum systems, advanced materials and artificial-intelligence-driven laboratories. They are opportunities to apply, not awards already made to companies.

What DOE opened

The larger opportunity is approximately $147 million in DOE Small Business Innovation Research and Small Business Technology Transfer Phase II funding. DOE says it supports eligible small businesses continuing technologies toward commercialization. Prior recipients of DOE SBIR/STTR Phase I, Phase II and Follow-on Phase II awards from earlier fiscal years will receive direct outreach with application requirements and timelines.

The separate Genesis Mission opportunity is for Phase I projects and anticipates about 40 awards. DOE identified four topic areas:

• Scaling the biotechnology revolution
• Artificial intelligence for quantum computing and networking
• Materials with predictable functionality
• AI-driven autonomous laboratories

The approximately 40 awards are an anticipated figure, not a final award count. Likewise, the approximately $147 million is the total opportunity amount described by DOE, not a guaranteed award for any individual company.

Who can apply

DOE describes SBIR and STTR as competitive, non-dilutive programs for for-profit U.S. small businesses that meet Small Business Administration eligibility requirements. The opportunities therefore are not automatically open to every small company.

The Phase I and Phase II tracks also serve different purposes. Phase I is designed to establish whether a proposed technology is technically feasible. Phase II advances eligible work through further development and prototyping. Later commercialization may occur through Phase III or other follow-on opportunities.

Companies should not treat the Genesis Mission Phase I opportunity and the Phase II funding as interchangeable. The Genesis opportunity focuses on specified topic areas, while the Phase II opening is directed to eligible companies continuing qualifying prior work.

Registrations should start early

DOE requires applicants to complete three registrations before submitting an application:

1. System for Award Management, or SAM
2. The SBA Company Registry
3. The DOE SBIR/STTR Application Hub

SAM registration generates the Unique Entity Identifier, or UEI, required for the application. DOE says SAM processing can take up to eight weeks, depending on capacity. The SBA registration requires the UEI, so companies need to begin the SAM process first. DOE says the SBA registration typically takes less than 10 minutes after the UEI is available, while Application Hub registration takes less than five minutes.

For businesses considering an application, the practical step is to begin the SAM process early and complete the other registrations once the UEI is available. An application cannot be submitted without the required registrations.

Why DOE changed the structure

The openings follow DOE’s April 28 consolidation of SBIR and STTR management under its Office of Technology Commercialization. DOE said the reorganization is intended to improve efficiency, streamline applications and reviews, strengthen partnerships with national laboratories and move federally funded research toward commercial use.

Those are DOE’s stated goals for the reorganization. The consolidation itself does not establish that the new structure has already improved commercialization outcomes.

Where the funding fits

DOE’s broader commercialization system includes programs that connect startups with national laboratories and help close the gap between research and market use. DOE said its Lab-Embedded Entrepreneurship Program has supported 239 fellows, helped launch more than 200 startups, attracted more than $6 billion in follow-on funding and contributed to nearly 4,000 jobs since 2015.

The separate Technology Commercialization Fund supports partnerships among DOE facilities, companies, universities and other organizations to move laboratory innovations toward the marketplace. Those programs provide context for the new SBIR/STTR openings: the funding is part of a broader lab-to-market pipeline rather than a standalone grant program.

Sources

• DOE SBIR/STTR program page